Hypertension and dyslipidemia management essentials (Record no. 16360)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01852nam a22005657a 4500 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | OSt |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20231106142118.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 220630s2010 maua|||| b||| 001 0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9780763759261 |
040 ## - CATALOGING SOURCE | |
Transcribing agency | QCPL |
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER | |
Classification number | 616.132061 |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Guthrie, Robert Miller |
Relator term | author |
245 10 - TITLE STATEMENT | |
Title | Hypertension and dyslipidemia management essentials |
Statement of responsibility, etc. | / Robert Miller Guthrie |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Place of production, publication, distribution, manufacture | Sudbury, Massachusetts : |
Name of producer, publisher, distributor, manufacturer | Physicians' Press, |
Date of production, publication, distribution, manufacture, or copyright notice | [2010] |
300 ## - PHYSICAL DESCRIPTION | |
Extent | vii, 136 pages : |
Other physical details | illustrations |
336 ## - Content Type | |
Source | rdacontent |
Content type term | text |
337 ## - MEDIA TYPE | |
Source | rdamedia |
Media type term | unmediated |
338 ## - Carrier Type | |
Source | rdacarrier |
Carrier type term | volume |
504 ## - BIBLIOGRAPHY, ETC. NOTE | |
Bibliography, etc | Includes bibliographical references (pages 120-132) and index. |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Section 1. Hypertension |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Hypertension management |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Diuretics |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Angiotensin-converting enzyme inhibitors ACE inhibitors |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Calcium channel blockers |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Angiotensin receptor blockers |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Beta-blockers |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Alpha-1 blockers |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Renin inhibitors |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Aldosterone receptor blockers |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Central agonists |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Direct vasodilators |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Peripheral adrenergic inhibitors |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Section 2. Cholesterol |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Hyperlipidemia |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Diagnosis and risk stratification |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Treatment issues |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Other diagnostic modalities |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | HMG-CoA reductase inhibitors (Statins) |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Ezetimibe |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | The fibrates (fibric acid derivatives) |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Niacin |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Bile acid sequestrates |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Omega-3 fish oils |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Torcetrapib |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Coenzyme Q |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Hypertension |
General subdivision | Chemotherapy |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Hypotensive agents |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Lipids |
General subdivision | Metabolism |
-- | Disorders |
-- | Chemotherapy |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Source of classification or shelving scheme | Dewey Decimal Classification |
Koha item type | Book |
Lost status | Library use only | Collection code | Permanent Location | Current Location | Shelving location | Date acquired | Source of acquisition | Full call number | Barcode | Koha item type |
---|---|---|---|---|---|---|---|---|---|---|
Circulation | Project 8 Branch | Project 8 Branch | Reference Section | 05/04/2022 | Donation | C 616.132 G984h 2010 | 122828d | Book |